ADNI
Predicted ADNI stages increased monotonically from CN to AD diagnosis groups. The ADNI analysis included 726 participants after excluding those missing any selected biomarker. Real-world evaluation used baseline ADNI ADNIMERGE visits from…
1 sources - 4 claims
Predicted ADNI stages increased monotonically from CN to AD diagnosis groups. The ADNI analysis included 726 participants after excluding those missing any selected biomarker. Real-world evaluation used baseline ADNI ADNIMERGE visits from CN, EMCI, LMCI, and AD participants. TEMPO's ADNI consensus sequence began with entorhinal, middle temporal, and fusiform biomarkers.